This federal Project Grant award of $633,755.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop and implement an integrated community-based approach called "Community Vital Signs (CVS)" to increase rates of blood pressure screening and connections to care for hypertension in Nigeria.
The award supports a two-phase project. In the R61 phase (Year 1), the grantee, Oregon Health & Science University, will engage stakeholders to refine and finalize the CVS strategies. In the R33 phase (Years 2-5), the strategies will be implemented and assessed at 12 community-based sites connected to 12 healthcare facilities across Nigeria. The project will evaluate the effectiveness of two different CVS strategies to connect individuals found to have high blood pressure readings to primary care. Key sub-awardees include the University of Nigeria Nsukka and Kaiser Foundation Hospitals.
The project promotes equitable access to hypertension diagnosis and care, with the potential to significantly increase early detection and management of this leading risk factor for cardiovascular disease and stroke in Nigeria.
Generated 12/3/24, 9:01 AM